Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
International Journal of Nuclear Medicine and Biology|January 1, 1982
L-3-123I-alpha-methyltyrosine for melanoma detection: a comparative evaluationG Kloster, H BockslaffNuklearmedizin. Nuclear Medicine|June 1, 1981
[Studies of cardiac metabolism with 123I-labelled fatty acids and 11C-methylglucose (author's transl)]K Vyska, A Höck, C Freundlieb, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1983
Bromine-75-labeled 1,4-benzodiazepines: potential agents for the mapping of benzodiazepine receptors in vivo: concise communicationH Scholl, G Kloster, G StöcklinThe Science of the Total Environment|November 1, 1993
Surfactants and complexing agents: new tasks for specimen banking?G Kloster, E Klumpp, M J SchwugerAlbrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe'S Archive for Clinical and Experimental Ophthalmology|January 1, 1981
Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosineH Bockslaff, M Spitznas, I Hahn, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1979
Accumulation of radioiodinated L-alpha-methyltyrosine in pancreas of mice: concise communicationU Tisljar, G Kloster, F Ritzl, et al.European Journal of Nuclear Medicine|January 1, 1983
75,77Br- and 123I-analogues of D-glucose as potential tracers for glucose utilisation in heart and brainG Kloster, P Laufer, W Wutz, et al.Biomedica Biochimica Acta|January 1, 1984
Effect of iloprost (ZK 36 374) on membrane integrity in ischemic rabbit heartsE F Smith, G Kloster, G Stöcklin, et al.European Journal of Nuclear Medicine|January 1, 1984
Omega-halofatty acids: a probe for mitochondrial membrane integrity. In vitro investigations in normal and ischaemic myocardiumG Kloster, G Stöcklin, E F Smith, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1981
15-(p[75Br]bromophenyl)pentadecanoic acid: pharmacokinetics and potential as heart agentH H Coenen, M F Harmand, G Kloster, et al.Pageof 2